FDA approves first therapy for Alexander disease - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

  • By

  • Kathryn Wighton

  • September 4, 2026

  • 2 min

Share

Original Source(s)

FDA approves first therapy for Alexander disease

  • by Kathryn Wighton

  • September 4, 2026

Related Content

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

FDA Clears Exoskeleton for Spinal Cord Injury

Use is limited to level indoor and adjoining outdoor areas and requires supervision by a companion with specialized training.

Patients engage with epilepsy monitor in real time, improving seizure detection

  • October 13, 2026